INTERWEST PARTNERS X LP - 13 Jul 2021 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
10%+ Owner
Signature
/s/ Karen A. Wilson, Attorney-in Fact for InterWest Partners X, LP
Issuer symbol
PMVP
Transactions as of
13 Jul 2021
Net transactions value
$0
Form type
4
Filing time
14 Jul 2021, 20:05:31 UTC
Previous filing
28 Jun 2021
Next filing
15 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PMVP Common Stock Other $0 -500,000 -10% $0.000000 4,469,911 13 Jul 2021 Direct F1
transaction PMVP Common Stock Other $0 +97,632 $0.000000 97,632 13 Jul 2021 By: InterWest Management Partners X, LLC F1, F3
transaction PMVP Common Stock Other $0 -97,632 -100% $0.000000* 0 13 Jul 2021 By: InterWest Management Partners X, LLC F2, F3
transaction PMVP Common Stock Other $0 +3,642 +652% $0.000000 4,201 13 Jul 2021 By: Khaled A. Nasr F2, F3
transaction PMVP Common Stock Other $0 +2,441 +651% $0.000000 2,816 13 Jul 2021 By: Keval Desai F2, F3
transaction PMVP Common Stock Other $0 +22,148 +651% $0.000000 25,552 13 Jul 2021 By Gilbert H. Kliman F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

INTERWEST PARTNERS X LP is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Represents pro rata in-kind distribution by InterWest Partners X, LP ("IW10") without consideration to its limited and general partners in accordance with the terms of the InterWest Partners X, LP Limited Partnership Agreement. Includes 97,632 shares distributed to InterWest Management Partners X, LLC ("IMP10") its general partner.
F2 Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 3,642 shares distributed to Khaled A. Nasr ("Nasr"), 2,441 shares distributed to Keval Desai ("Desai") and 22,148 shares distributed to Gilbert H. Kliman ("Kliman").
F3 The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein.